| Literature DB >> 26670350 |
Marta Czerska1, Marek Zieliński2, Jolanta Gromadzińska3.
Abstract
Isoprostanes are a recently discovered group of prostaglandin isomers. Results of previous studies suggest that they can be used as oxidative stress markers, because in a number of cardiovascular, pulmonary and neurological diseases their levels in biological samples considerably increase. It has been found that people suffering from diabetes, obesity, homozygous familial hypercholesterolemia, moderate hypercholesterolemia, and smokers have higher levels of isoprostanes in urine. The same refers to patients with asthma, Alzheimer disease and Down syndrome. This paper reviews the results of relevant studies. This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.Entities:
Keywords: asbestosis; cardiovascular; isoprostanes; neurological; oxidative stress biomarkers; pulmonary
Mesh:
Substances:
Year: 2016 PMID: 26670350 DOI: 10.13075/ijomeh.1896.00596
Source DB: PubMed Journal: Int J Occup Med Environ Health ISSN: 1232-1087 Impact factor: 1.843